Phase 3 clinical trial data show efficacy of BARHEMSYS in treatment of post-operative nausea and vomiting
Acacia Pharma Group plc recently announced that data and analyses from its positive Phase 3 clinical trial with BARHEMSYS™ (intravenous amisulpride)...
Read More